Seven novel spiromeroterpenoids,
asnovolins A–G (1–7), one
of which was shown to suppress fibronectin expression, were isolated
from Aspergillus novofumigatus CBS117520 along with
a known compound, novofumigatonin (8). The structures
of asnovolins A–G were elucidated using MS and 2D-NMR data.
Asnovolin E (5) suppressed fibronectin expression by
normal human neonatal dermal fibroblast cells.